Меню

• Главная
• Публикации
  • 2024-2027
    • Proinflammatory Activation of Monocytes in Patients with Immunoinflammatory Rheumatic Diseases
    • Inflammatory Response of Monocytes/Macrophages in Patients with Systemic Sclerosis
    • The Role of Bacterial Extracellular Membrane Nanovesicles in Atherosclerosis: Unraveling a Potential Trigger
    • Relationship between Cellular Oxygen Consumption and Atherosclerosis-Associated Mitochondrial Mutations (Variants of the Mitochondrial Genome)
    • Molecular Aspects of Inflammation and Lipid Metabolism in Health and Disease: The Role of the Mitochondria
    • Influence of antibiotics on the development of mitochondrial dysfunction
    • Atherosclerosis originating from childhood: Specific features
    • Potential use of antioxidants for the treatment of chronic inflammatory diseases
    • Mitochondrial Genome Editing: Exploring the Possible Relationship of the Atherosclerosis-Associated Mutation m.15059G>A With Defective Mitophagy
    • Coronary atherosclerotic plaque regression strategies
    • Target Role of Monocytes as Key Cells of Innate Immunity in Rheumatoid Arthritis
    • Role of ABCA1 in Atherosclerosis: Novel Mutations and Potential Plant-derived Therapies
    • The association of TNF-alpha secretion and mtDNA copy number in CD14+ monocytes of patients with obesity and CHD
    • We Must Abandon the Myth: Oxidized Low-density Lipoprotein is not a Lipoprotein that Plays a Key Role in Atherogenesis
    • Defective Mitophagy Impairs Response to Inflammatory Activation of Macrophage-Like Cells
    • Evidence for the Involvement of Gene Regulation of Inflammatory Molecules in the Accumulation of Intracellular Cholesterol: The Mechanism of Foam Cell Formation in Atherosclerosis
    • The role of mitochondria in metastasis development
  • 2020-2023
    • Effect of 5-aminolevulinic Acid on Mitochondrial Activity
    • Sialic acid as the potential link between lipid metabolism and inflammation in the pathogenesis of atherosclerosis
    • Macrophages derived from LPS-stimulated monocytes from individuals with subclinical atherosclerosis were characterized by increased pro-inflammatory activity
    • Fuling-Zexie formula attenuates hyperuricemia-induced nephropathy and inhibits JAK2/STAT3 signaling and NLRP3 inflammasome activation in mice
    • Regulatory T Cells in Atherosclerosis: Is Adoptive Cell Therapy Possible?
    • Mechanisms of the Wnt Pathways as a Potential Target Pathway in Atherosclerosis
    • Is There a Relationship between Adverse Pregnancy Outcomes and Future Development of Atherosclerosis?
    • Statins as a Potential Treatment for Non-Alcoholic Fatty Liver Disease: Target Deconvolution using Protein-protein Interaction Network Analysis
    • Long Non-Coding RNAs in Colorectal Cancer: Navigating the Intersections of Immunity, Intercellular Communication, and Therapeutic Potential
    • Potential Use of Antioxidant Compounds for the Treatment of Inflammatory Bowel Disease
    • Potential Application of the Plant-Derived Essential Oils for Atherosclerosis Treatment: Molecular Mechanisms and Therapeutic Potential
    • Sex Differences Define the Vulnerability to Atherosclerosis
    • Atheroprotective Aspects of Heat Shock Proteins
    • Oligosaccharides as Potential Therapeutics against Atherosclerosis
    • The Role of Selenium in Atherosclerosis Development, Progression, Prevention and Treatment
    • Type 1 diabetes mellitus: Inflammation, mitophagy, and mitochondrial function
    • Diagnostics of atherosclerosis: Overview of the existing methods
    • Simiao San alleviates hyperuricemia and kidney inflammation by inhibiting NLRP3 inflammasome and JAK2/STAT3 signaling in hyperuricemia mice
    • Epac as a tractable therapeutic target
    • Impaired Mitochondrial Function in T-Lymphocytes as a Result of Exposure to HIV and ART
    • HDL-Based Therapy: Vascular Protection at All Stages
    • Hypotheses on Atherogenesis Triggering: Does the Infectious Nature of Atherosclerosis Development Have a Substruction?
    • The Role of Pericytes in Regulation of Innate and Adaptive Immunity
    • Creation of Mitochondrial Disease Models Using Mitochondrial DNA Editing
    • Proprotein Convertase Subtilisin/Kexin 9 as a Modifier of Lipid Metabolism in Atherosclerosis
    • The Role of Macrophages in the Pathogenesis of Atherosclerosis
    • Glycation of LDL: AGEs, impact on lipoprotein function, and involvement in atherosclerosis
    • Effect of nano-curcumin on various diseases: A comprehensive review of clinical trials
    • The effect of combination therapy with statins and ezetimibe on proinflammatory cytokines: A systematic review and meta-analysis of randomized controlled trials
    • Emerging role of pericytes in therapy of cardiovascular diseases
    • Involvement of Bacterial Extracellular Membrane Nanovesicles in Infectious Diseases and Their Application in Medicine
    • Targeting Mitochondrial Dynamics Proteins for the Development of Therapies for Cardiovascular Diseases
    • Activated cholesterol metabolism is integral for innate macrophage responses by amplifying Myd88 signaling
    • Prospects for the Development of Pink1 and Parkin Activators for the Treatment of Parkinson's Disease
    • Effect of Curcumin on Glycaemic and Lipid Parameters in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    • Significance of Mitochondrial Dysfunction in the Progression of Multiple Sclerosis
    • Familial Hypercholesterolaemia as a Predisposing Factor for Atherosclerosis
    • Molecular Mechanisms Underlying Pathological and Therapeutic Roles of Pericytes in Atherosclerosis
    • Effect of Glucose Levels on Cardiovascular Risk
    • Anti-lung cancer properties of cyanobacterial bioactive compounds
    • Atherosclerosis Specific Features in Chronic Kidney Disease (CKD)
    • From Diabetes to Atherosclerosis: Potential of Metformin for Management of Cardiovascular Disease
    • Hypertension as a risk factor for atherosclerosis: Cardiovascular risk assessment
    • Retraction notice to " Endothelial PECAM-1 and its function in vascular physiology and atherogenic pathology" [Experimental and Molecular Pathology 100 (2016) 409-415]
    • Retraction notice to "The role of cardiac fibroblasts in post-myocardial heart tissue repair" [Experimental and Molecular Pathology 101/2 (2016) 231-240]
    • Phenotype Diversity of Macrophages in Osteoarthritis: Implications for Development of Macrophage Modulating Therapies
    • Atheroprotective Effects of Glycyrrhiza glabra L
    • The Role of Mitochondrial Abnormalities in Diabetic Cardiomyopathy
    • Effects of Metabolic Disorders in Immune Cells and Synoviocytes on the Development of Rheumatoid Arthritis
    • The expanding roles of neuronal nitric oxide synthase (NOS1)
    • Role of Impaired Mitochondrial Dynamics Processes in the Pathogenesis of Alzheimer's Disease
    • Aging of Vascular System Is a Complex Process: The Cornerstone Mechanisms
    • Interplay between Zn 2+ Homeostasis and Mitochondrial Functions in Cardiovascular Diseases and Heart Ageing
    • Mechanisms underlying the effects of caloric restriction on hypertension
    • Novel Models of Crohn's Disease Pathogenesis Associated with the Occurrence of Mitochondrial Dysfunction in Intestinal Cells
    • Cysteine-rich protein 2 deficiency attenuates angiotensin II-induced abdominal aortic aneurysm formation in mice
    • Somatic Mutations of Hematopoietic Cells Are an Additional Mechanism of Body Aging, Conducive to Comorbidity and Increasing Chronification of Inflammation
    • Mitochondrial Implications in Cardiovascular Aging and Diseases: The Specific Role of Mitochondrial Dynamics and Shifts
    • Atherosclerosis in HIV Patients: What Do We Know so Far?
    • Vaccination against Atherosclerosis: Is It Real?
    • Functional Phenotypes of Intraplaque Macrophages and Their Distinct Roles in Atherosclerosis Development and Atheroinflammation
    • Atherosclerosis amelioration by allicin in raw garlic through gut microbiota and trimethylamine-N-oxide modulation
    • Cholesterol Transport Dysfunction and Its Involvement in Atherogenesis
    • Role of the mtDNA Mutations and Mitophagy in Inflammaging
    • The Role of KLF2 in the Regulation of Atherosclerosis Development and Potential Use of KLF2-Targeted Therapy
    • Modulating mTOR Signaling as a Promising Therapeutic Strategy for Atherosclerosis
    • Local Accumulation of Lymphocytes in the Intima of Human Aorta Is Associated with Giant Multinucleated Endothelial Cells: Possible Explanation for Mosaicism of Atherosclerosis
    • The Role of Mitochondrial DNA Mutations in Cardiovascular Diseases
    • The Role of the VEGF Family in Atherosclerosis Development and Its Potential as Treatment Targets
    • BaZiBuShen alleviates cognitive deficits and regulates Sirt6/NRF2/HO-1 and Sirt6/P53-PGC-1α-TERT signaling pathways in aging mice
    • A comprehensive review on the phytochemistry, pharmacokinetics, and antidiabetic effect of Ginseng
    • Fructus Ligustri Lucidi aqueous extract promotes calcium balance and short-chain fatty acids production in ovariectomized rats
    • Effect of Curcumin on Glycaemic and Lipid Parameters in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    • The role of mitochondria dysfunction and hepatic senescence in NAFLD development and progression
    • BaZiBuShen alleviates cognitive deficits and regulates Sirt6/NRF2/HO-1 and Sirt6/P53-PGC-1α-TERT signaling pathways in aging mice
    • Macrophages and Foam Cells: Brief Overview of Their Role, Linkage, and Targeting Potential in Atherosclerosis
    • A comprehensive review on the phytochemistry, pharmacokinetics, and antidiabetic effect of Ginseng
    • The Role of Mitochondria-Derived Peptides in Cardiovascular Diseases and Their Potential as Therapeutic Targets
    • The role of mitochondria dysfunction and hepatic senescence in NAFLD development and progression
    • Anti-Inflammatory Therapy for Atherosclerosis: Focusing on Cytokines
    • Mitochondrial Lipid Homeostasis at the Crossroads of Liver and Heart Diseases
    • The Role of Mitochondrial Mutations and Chronic Inflammation in Diabetes
    • Renin-Angiotensin System in Pathogenesis of Atherosclerosis and Treatment of CVD
    • Fructus Ligustri Lucidi aqueous extract promotes calcium balance and short-chain fatty acids production in ovariectomized rats
    • Pathophysiological Aspects of the Development of Abdominal Aortic Aneurysm with a Special Focus on Mitochondrial Dysfunction and Genetic Associations
    • The Role of Mitochondrial Dysfunction in Vascular Disease, Tumorigenesis, and Diabetes
    • Atherosclerosis as Mitochondriopathy: Repositioning the Disease to Help Finding New Therapies
    • Prospects for the Use of Sialidase Inhibitors in Anti-atherosclerotic Therapy
    • ACE2 Is an Adjacent Element of Atherosclerosis and COVID-19 Pathogenesis
    • Mitochondrial Mutations and Genetic Factors Determining NAFLD Risk
    • Macrophages in Health and Non-Infectious Disease
    • Immunopathology of Atherosclerosis and Related Diseases: Focus on Molecular Biology
    • Mitochondrial Dysfunction and Chronic Inflammation in Polycystic Ovary Syndrome
    • An original biomarker for the risk of developing cardiovascular diseases and their complications: Telomere length
    • Involvement of Oxidative Stress and the Innate Immune System in SARS-CoV-2 Infection
    • Disturbance of Mitochondrial Dynamics and Mitochondrial Therapies in Atherosclerosis
    • Autophagy and Mitophagy as Essential Components of Atherosclerosis
    • Role of Telomeres Shortening in Atherogenesis: An Overview
    • Retraction notice to Macrophage phenotypic plasticity in atherosclerosis: The associated features and the peculiarities of the expression of inflammatory genes, International Journal of Cardiology, Volume 184, 1 April 2015, Pages 436-445
    • Neuraminidases 1 and 3 Trigger Atherosclerosis by Desialylating Low-Density Lipoproteins and Increasing Their Uptake by Macrophages
    • Two Subpopulations of Human Monocytes That Differ by Mitochondrial Membrane Potential
    • BaZiBuShen alleviates altered testicular morphology and spermatogenesis and modulates Sirt6/P53 and Sirt6/NF-κB pathways in aging mice induced by D-galactose and NaNO2
    • Pro-inflammatory molecules induce cholesterol accumulation in macrophages: Role of inflammatory response in foam cell formation
    • Some Molecular and Cellular Stress Mechanisms Associated with Neurodegenerative Diseases and Atherosclerosis
    • Overview of OxLDL and Its Impact on Cardiovascular Health: Focus on Atherosclerosis
    • Mechanistic factors of cardiovascular diseases
    • Therapeutic Potential of Heme Oxygenase-1 in Aneurysmal Diseases
    • Characterization of TMAO productivity from carnitine challenge facilitates personalized nutrition and microbiome signatures discovery
    • Comparative analysis of the variability of carotid intima-media thickness in primary prevention populations of Moscow and Paris
    • Do mitochondrial DNA mutations play the key role in chronification of sterile inflammation? Special focus on atherosclerosis
    • A Novel Insight at Atherogenesis: The Role of Microbiome
    • Prospects for the Use of Sialidase Inhibitors in Anti-atherosclerotic Therapy
    • Noninvasive Testing for Diagnosis of Stable Coronary Artery Disease in the Elderly
    • Impact of Mitochondrial DNA Mutations on Carotid Intima-Media Thickness in the Novosibirsk Region
    • Genetics of Arterial-Wall-Specific Mechanisms in Atherosclerosis: Focus on Mitochondrial Mutations
    • Relationship Between Plasma Osteopontin and Arginine Pathway Metabolites in Patients With Overt Coronary Artery Disease
    • Sex-Specific Features of Calcific Aortic Valve Disease
    • Lipid Metabolism in Macrophages: Focus on Atherosclerosis
    • Sialylated Immunoglobulins for the Treatment of Immuno-Inflammatory Diseases
    • Sialidase Activity in Human Blood Serum Has a Distinct Seasonal Pattern: A Pilot Study
    • Endoplasmic Reticulum Stress in Macrophages: The Vicious Circle of Lipid Accumulation and Pro-Inflammatory Response
    • NADPH Oxidases and Their Role in Atherosclerosis
    • NLPR3 Inflammasomes and Their Significance for Atherosclerosis
    • The Link between Chronic Stress and Accelerated Aging
    • Gut Microbiome: A Possible Common Therapeutic Target for Treatment of Atherosclerosis and Cancer
    • Mitochondrial Dysfunction and DNA Damage in the Context of Pathogenesis of Atherosclerosis
    • The Role of Sialic Acids in the Initiation of Atherosclerosis
    • Animal Models of Human Atherosclerosis: Current Progress
    • Cellular Mechanisms of Human Atherogenesis: Focus on Chronification of Inflammation and Mitochondrial Mutations
    • Exposure to Zinc Oxide Nanoparticles Disrupts Endothelial Tight and Adherens Junctions and Induces Pulmonary Inflammatory Cell Infiltration.
    • Current Advances in the Diagnostic Imaging of Atherosclerosis: Insights into the Pathophysiology of Vulnerable Plaque.
    • Clinical Effectiveness of a Combination of Black Elder Berries, Violet Herb, and Calendula Flowers in Chronic Obstructive Pulmonary Disease: The Results of a Double-Blinded Placebo-Controlled Study.
    • Medicinal Plants as a Potential and Successful Treatment Option in the Context of Atherosclerosis.
    • Signaling Pathways Potentially Responsible for Foam Cell Formation: Cholesterol Accumulation or Inflammatory Response-What is First?
    • Oxidative Stress and Antioxidants in Atherosclerosis Development and Treatment.
    • Possible Role of Mitochondrial DNA Mutations in Chronification of Inflammation: Focus on Atherosclerosis.
    • Lipid-based gene delivery to macrophage mitochondria for atherosclerosis therapy.
    • Contribution of Neurotrophins to the Immune System Regulation and Possible Connection to Alcohol Addiction.
    • In Search for Genes Related to Atherosclerosis and Dyslipidemia Using Animal Models.
    • Carotid Atherosclerosis Progression in Postmenopausal Women Receiving a Mixed Phytoestrogen Regimen: Plausible Parallels with Kronos Early Estrogen Replacement Study
    • The Diabetes Mellitus-Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation
    • Signaling Pathways and Key Genes Involved in Regulation of foam Cell Formation in Atherosclerosis
    • Role of Phagocytosis in the Pro-Inflammatory Response in LDL-Induced Foam Cell Formation; a Transcriptome Analysis
    • Data on association of mitochondrial heteroplasmy with carotid intima-media thickness in subjects from Russian and Kazakh populations
    • Atherosclerosis prevention: the role of special diets and functional food
    • The role of mitochondria in cardiovascular diseases related to atherosclerosis
    • Prevention of atherosclerosis: the role of special diets and functional foods
  • 2016-2019
    • Modelling of atherosclerosis in genetically modified animals.
    • Heteroplasmic Variants of Mitochondrial DNA in Atherosclerotic Lesions of Human Aortic Intima.
    • Creation of Cybrid Cultures Containing mtDNA Mutations m.12315G>A and m.1555G>A, Associated with Atherosclerosis.
    • Trained Circulating Monocytes in Atherosclerosis: Ex Vivo Model Approach.
    • The Atherogenic Role of Circulating Modified Lipids in Atherosclerosis.
    • Modern approaches for modelling dystonia and Huntington's disease in vitro and in vivo.
    • An update on the tools for creating transgenic animal models of human diseases - focus on atherosclerosis.
    • Inhibitors of DNA methylation and histone deacetylation as epigenetically active drugs for anticancer therapy.
    • Trans-sialidase associated with atherosclerosis : defining the identity of a key enzyme involved in the pathology.
    • Human disease modelling techniques: current progress.
    • Novel approaches to anti-atherosclerotic therapy: Cell-based models and herbal preparations (Review of our own data).
    • Translation of Basic Research into Clinical Practice: Focus on Cell-Based Diagnostics and Therapy.
    • Current Approaches to Diagnostics and Therapies of Chronic Diseases: Focus on Molecular and Cell Biology.
    • Aqueous Extract of Mori Folium Exerts Bone Protective Effect Through Regulation of Calcium and Redox Homeostasis via PTH/VDR/CaBP and AGEs/RAGE/Nox4/NF-κB Signaling in Diabetic Rats.
    • Sialidase activity in human pathologies.
    • Role of androgens in cardiovascular pathology.
    • Mitochondrial diseases caused by mtDNA mutations: a mini-review.
    • Inhibition of sialidase activity as a therapeutic approach.
    • Matrix metalloproteinases in pro-atherosclerotic arterial remodeling.
    • Diagnostics and Therapy of human diseases - Focus on sialidases.
    • Tumor necrosis factor-α and C-C motif chemokine ligand 18 associate with atherosclerotic lipid accumulation in situ and in vitro.
    • Modified Ldl Particles Activate Inflammatory Pathways In Monocyte-Derived Macrophages: Transcriptome Analysis.
    • Response to: Comment on "Role of Mitochondrial Genome Mutations in Pathogenesis of Carotid Atherosclerosis".
    • Rehmanniae Radix Preparata suppresses bone loss and increases bone strength through interfering with canonical Wnt/β-catenin signaling pathway in OVX rats.
    • HDL activates expression of genes stimulating cholesterol efflux in human monocyte-derived macrophages.
    • Atherosclerosis in subjects newly diagnosed with human immunodeficiency virus infection.
    • Cybrid Models of Pathological Cell Processes in Different Diseases.
    • Data on association of mitochondrial heteroplasmy and cardiovascular risk factors: Comparison of samples from Russian and Mexican populations.
    • LDL and foam cell formation as the basis of atherogenesis.
    • Mitochondrial Genome Mutations Associated with Myocardial Infarction.
    • Modified and Dysfunctional Lipoproteins in Atherosclerosis: Effectors or Biomarkers?
    • Phytotherapy for the Prevention of Atherosclerosis-Associated Early Cerebral Ischemia.
    • Mitochondrial genome variability: the effect on cellular functional activity.
    • Potential of anti-inflammatory agents for treatment of atherosclerosis.
    • The role of monocytosis and neutrophilia in atherosclerosis.
    • New biomarkers for diagnosis and prognosis of localized prostate cancer.
    • Mutations of nuclear and mitochondrial genomes as potential targets for the treatment of metabolic syndrome.
    • Modified lipoproteins as biomarkers of atherosclerosis.
    • Influence of autophagy on the genesis and development of atherosclerosis and its risk factors.
    • Calcifying Matrix Vesicles and Atherosclerosis.
    • The role of mitochondrial dysfunction in cardiovascular disease: a brief review.
    • [Study of mitochondrial dysfunction using cytoplasmic hybrid].
    • Engineered nanoparticles: Their properties and putative applications for therapeutic approaches utilizing stem cells for the repair of atherosclerotic disease.
    • The impact of interferon-regulatory factors to macrophage differentiation and polarization into M1 and M2
    • An immunoregulatory role of dendritic cell-derived exosomes versus HIV-1 infection: take it easy but be warned.
    • [Peculiarities of secretion of cytokines and chemokines by human blood monocytes in atherosclerosis].
    • Role of lipids and intraplaque hypoxia in the formation of neovascularization in atherosclerosis.
    • Mechanisms of foam cell formation in atherosclerosis.
    • The impact of FOXO-1 to cardiac pathology in diabetes mellitus and diabetes-related metabolic abnormalities.
    • Thrombospondins: A Role in Cardiovascular Disease.
    • Impact of the cardiovascular system-associated adipose tissue on atherosclerotic pathology.
    • Phytoestrogen-Rich Natural Preparation for Treatment of Climacteric Syndrome and Atherosclerosis Prevention in Perimenopausal Women.
    • Small Dense Low-Density Lipoprotein as Biomarker for Atherosclerotic Diseases.
    • The effect of maximal vs submaximal exertion on postprandial lipid levels in individuals with and without coronary heart disease.
    • Macrophages and Their Contribution to the Development of Atherosclerosis.
    • Chemokines and Relevant microRNAs in the Atherogenic Process.
    • Nanocarriers in improving chemotherapy of multidrug resistant tumors: Key developments and perspective.
    • Editorial: Conventional, Traditional and Alternative Therapies for Cardiovascular Disorders.
    • Cell-Based Models for Development of Antiatherosclerotic Therapies.
    • Analysis of Apolipoprotein B Protein of Circulating Multiple-Modified Low-Density Lipoprotein.
    • Multiple-modified Low-Density Lipoprotein as Atherogenic Factor of patients' Blood: Development of Therapeutic Approaches to reduce blood Atherogenicity.
    • The phenomenon of atherosclerosis reversal and regression: Lessons from animal models.
    • Use of Primary Macrophages for Searching Novel Immunocorrectors.
    • Blood Serum Atherogenicity: Cellular Test for the Development of Anti-Atherosclerotic Therapy.
    • How do macrophages sense modified low-density lipoproteins?
    • [Modified circulating low-density lipoproteins: pathogenetic significance in angiology].
    • Poor glycemic control in type 2 diabetes enhances functional and compositional alterations of small, dense HDL3c.
    • Treatment of cardiovascular pathology with epigenetically active agents: Focus on natural and synthetic inhibitors of DNA methylation and histone deacetylation.
    • Peroxisome proliferator-activated receptor (PPAR) gamma agonists as therapeutic agents for cardiovascular disorders: Focus on atherosclerosis.
    • CD68/macrosialin: not just a histochemical marker.
    • Carbohydrate composition of circulating multiple-modified low-density lipoprotein.
    • Epigenetically active drugs inhibiting DNA methylation and histone deacetylation.
    • Sialidases: Therapeutic And Antiatherogenic Potential.
    • Paraoxonase and atherosclerosis-related cardiovascular diseases
    • PPAR Agonists, Atherogenic Dyslipidemia and Cardiovascular Risk.
    • The role of cardiac fibroblasts in post-myocardial heart tissue repair.
    • [Atherogenic modification of low-density lipoproteins]
    • Lipid composition of circulating multiple-modified low density lipoprotein.
    • PPAR in Cardiovascular Disorders.
    • Anti-Atherosclerotic Effects of a Phytoestrogen-Rich Herbal Preparation in Postmenopausal Women.
    • Evidence based efficacy of herbal preparations in ageing associated cardiovascular disorders.
    • Macrophages and Their Role in Atherosclerosis: Pathophysiology and Transcriptome Analysis.
    • Effects of shear stress on endothelial cells: go with the flow.
    • Immune-inflammatory responses in atherosclerosis: Role of an adaptive immunity mainly driven by T and B cells.
    • [Epigenetic factors in atherogenesis: microRNA].
    • LOX-1-Mediated Effects on Vascular Cells in Atherosclerosis.
    • The role of miR-126 in embryonic angiogenesis, adult vascular homeostasis, and vascular repair and its alterations in atherosclerotic disease.
    • ApoA1 and ApoA1-specific self-antibodies in cardiovascular disease.
    • Dataset of mitochondrial genome variants associated with asymptomatic atherosclerosis.
    • Endothelial PECAM-1 and its function in vascular physiology and atherogenic pathology.
    • Cardiac-specific miRNA in cardiogenesis, heart function, and cardiac pathology (with focus on myocardial infarction).
    • Cellular models of atherosclerosis and their implication for testing natural substances with anti-atherosclerotic potential.
    • Monocyte Activation in Immunopathology: Cellular Test for Development of Diagnostics and Therapy.
    • Cellular Model of Atherogenesis Based on Pluripotent Vascular Wall Pericytes.
    • [Macrophage activation in atherosclerosis. Message 1: Activation of macrophages normally and in atherosclerotic lesions].
    • [Ability of human monocytes to activate in atherosclerosis].
    • Dendritic Cells in Colorectal Cancer and a Potential for their Use in Therapeutic Approaches.
    • The Role of Endoplasmic Reticulum Stress and Unfolded Protein Response in Atherosclerosis.
    • Links between atherosclerotic and periodontal disease.
    • Anti-cytokine therapy for prevention of atherosclerosis.
    • Cellular mechanisms of human atherosclerosis: Role of cell-to-cell communications in subendothelial cell functions.
    • Cardiac Extracellular Vesicles in Normal and Infarcted Heart.
    • Anti-atherosclerotic effects of garlic preparation in freeze injury model of atherosclerosis in cholesterol-fed rabbits.
    • Editorial: Mechanistic Biomarkers: The Field for the Development of Non-Pharmaceutical and Pharmaceutical Approaches to Diagnostics, Prevention and Treatment of Chronic Diseases.
    • Editorial: The Crosstalk between Non-Pharmaceutical and Pharmaceutical Approaches to Prevention and Treatment of Chronic Diseases: Current Concepts and Perspectives.
  • 2013-2015
    • Механизмы оттока холестерина из макрофагов — роль белка переноса фосфолипидов
    • Endothelial Barrier and Its Abnormalities in Cardiovascular Disease.
    • Analysis of mitochondrial DNA heteroplasmic mutations A1555G, C3256T, T3336C, С5178А, G12315A, G13513A, G14459A, G14846А and G15059A in CHD patients with the history of myocardial infarction.
    • Association of mitochondrial mutations with the age of patients having atherosclerotic lesions.
    • T Helper Lymphocyte Subsets and Plasticity in Autoimmunity and Cancer: An Overview.
    • Phytoestrogen-Rich Dietary Supplements in Anti-Atherosclerotic Therapy in Postmenopausal Women.
    • Mitochondrial genome sequencing in atherosclerosis: what's next?
    • Antiatherosclerotic and Cardioprotective Effects of Time-Released Garlic Powder Pills.
    • Dendritic Cells in Esophageal Adenocarcinoma: The Currently Available Information and Possibilities to use Dendritic Cells for Immunotherapeutic Approaches.
    • Susceptibility of monocytes to activation correlates with atherogenic mitochondrial DNA mutations
    • Inhibitory Effect of Polyethylene Oxide and Polypropylene Oxide Triblock Copolymers on Aggregation and Fusion of Atherogenic Low Density Lipoproteins
    • Intimal pericytes as the second line of immune defence in atherosclerosis
    • Macrophage-mediated cholesterol handling in atherosclerosis.
    • MAJOR MOLECULAR AND CELLULAR MANIFESTATIONS OF ATHEROSCLEROSIS
    • Study of the activated macrophage transcriptome
    • Mosaicism of mitochondrial mutations G15059A and G14846A of cytochrome B gene in atherosclerotic lesions of human aortic intima
    • Influence of Dendritic Cells microenvironment on their role in in flammatory processes of atherogenesis
    • Development of Antiatherosclerotic Drugs on the basis of Natural Products Using Cell Model Approach.
    • LDL electronegativity index: a potential novel index for predicting cardiovascular disease
    • Human miR-221/222 in Physiological and Atherosclerotic Vascular Remodeling.
    • Conventional and novel cardiovascular risk factors and predisposition to the development of atherosclerosis
    • Analysis of mitochondrial haplogroups in persons with subclinical atherosclerosis based on high-throughput mtDNA sequencing
    • Role of gut microbiota in the modulation of atherosclerosis-associated immune response.
    • Vascular stem/progenitor cells: current status of the problem.
    • Innervation of the arterial wall and its modification in atherosclerosis.
    • 1A.06: MITOCHONDRIAL DNA HAPLOGROUP H IS ASSOCIATED WITH SUBCLINICAL CAROTID ATHEROSCLEROSIS IN RUSSIAN POPULATION.
    • Phenomenon of individual difference in human monocyte activation.
    • Peroxisome proliferator-activated receptor (PPAR) gamma in cardiovascular disorders and cardiovascular surgery
    • Changes in transcriptome of macrophages in atherosclerosis.
    • Quantitative analysis of the expression of caspase 3 and caspase 9 in different types of atherosclerotic lesions in the human aorta
    • Association of mutations in the mitochondrial genome with the subclinical carotid atherosclerosis in women.
    • Extracellular vesicles and atherosclerotic disease
    • Mutations of mitochondrial genome in carotid atherosclerosis.
    • Mosaicism of mitochondrial genetic variation in atherosclerotic lesions of the human aorta
    • Vascular Endothelium: Functioning in Norm, Changes in Atherosclerosis and Current Dietary Approaches to improve Endothelial Function.
    • Macrophage phenotypic plasticity in atherosclerosis: The associated features and the peculiarities of the expression of inflammatory genes.
    • MicroRNAs in Esophageal Adenocarcinoma: Functional Significance and Potential for the Development of New Molecular Disease Markers.
    • Vascular smooth muscle cell in atherosclerosis.
    • Heterogeneity of Tregs and the complexity in the IL-12 cytokine family signaling in driving T-cell immune responses in atherosclerotic vessels.
    • Intestinal mucosal tolerance and impact of gut microbiota to mucosal tolerance.
    • Myeloid dendritic cells: Development, functions, and role in atherosclerotic inflammation
    • Mitochondrial Aging: Focus on Mitochondrial DNA Damage in Atherosclerosis - A Mini-Review
    • Contribution of neovascularization and intraplaque haemorrhage to atherosclerotic plaque progression and instability
    • Expression and secretion of cytokines in the intima of the aorta and in macrophages during atherogenesis
    • Inflammation, immune cells, cytokines — role in atherogenesis
    • Macrophages in Immunopathology of Atherosclerosis: a Target for Diagnostics and Therapy.
    • Mutations of Mitochondrial DNA in Atherosclerosis and Atherosclerosis-Related Diseases.
    • Dendritic Cells: A double-edge Sword in Atherosclerotic Inflammation.
    • Novel Anti-inflammatory Interleukin-35 as an Emerging Target for Anti-atherosclerotic Therapy.
    • High Expression of Cathepsin E in Tissues but Not Blood of Patients with Barrett's Esophagus and Adenocarcinoma.
    • A Systematic Review and Metaanalysis on the Effects of Garlic Preparations on Blood Pressure in Individuals With Hypertension
    • Plasmacytoid dendritic cells: development, functions, and role in atherosclerotic inflammation
    • Approach to reduction of blood atherogenicity.
    • Role of Endoplasmic Reticulum Stress in Atherosclerosis and Diabetic Macrovascular Complications.
    • Low Density Lipoprotein-Containing Circulating Immune Complexes: Role in Atherosclerosis and Diagnostic Value.
    • Modified low density lipoprotein and lipoprotein-containing circulating immune complexes as diagnostic and prognostic biomarkers of atherosclerosis and type 1 diabetes macrovascular disease.
    • The complexity of cell composition of the intima of large arteries: Focus on pericyte-like cells.
    • Dendritic cells in atherosclerotic inflammation: the complexity of functions and the peculiarities of pathophysiological effects.
    • Quantitative assessment of heteroplasmy of mitochondrial genome: perspectives in diagnostics and methodological pitfalls.
    • Mitochondrial aging and age-related dysfunction of mitochondria.
    • [Direct antiatherosclerotic therapy: possible approaches, results of clinical trials].
    • Role of Bone-Type Tissue-Nonspecific Alkaline Phosphatase and PHOSPO1 in Vascular Calcification.
    • Blood Serum Atherogenicity and Coronary Artery Calcification.
    • Mechanisms of Medial Arterial Calcification in Diabetes.
    • Effect of sex hormones on levels of mRNAs coding for proteins involved in lipid metabolism in macrophages.
    • Coordination in gene expression during atherogenesis.
    • Association of mitochondrial genetic variation with carotid atherosclerosis.
    • Changes in levels of gene expression in human aortal intima during atherogenesis.
    • Interaction of native and modified low density lipoprotein with intimal cells in atherosclerotic lesion
    • Lipid regulators during atherogenesis: expression of LXR, PPAR, and SREBP mRNA in the human aorta.
    • Association of the level of heteroplasmy of the 15059G>A mutation in the MT-CYB mitochondrial gene with essential hypertension.
    • Changes of lysosomes in the earliest stages of the development of atherosclerosis.
    • Blood Atherogenicity as a Target for Anti-atherosclerotic Therapy.
    • Mitochondrial mutations in atherosclerosis: new solutions in research and possible clinical applications.
    • Direct anti-atherosclerotic therapy; development of natural anti-atherosclerotic drugs preventing cellular cholesterol retention.
    • Vascular extracellular matrix in atherosclerosis.
    • Regulatory T cells in atherosclerosis and strategies to induce the endogenous atheroprotective immune response.
    • Changes of mitochondria in atherosclerosis: possible determinant in the pathogenesis of the disease.
    • Anti-atherosclerotic therapy based on botanicals.
    • Diagnostic and prognostic value of low density lipoprotein-containing circulating immune complexes in atherosclerosis.
    • Low density lipoprotein-containing circulating immune complexes have better prognostic value in carotid intima-media thickness progression than other lipid parameters.
    • Increased shedding of microvesicles from intimal smooth muscle cells in athero-prone areas of the human aorta: implications for understanding of the predisease stage.
  • 2009-2012
    • Макрофаги и метаболизм липопротеидов в атеросклеротическом поражении
    • Widespread distribution of HLA-DR-expressing cells in macroscopically undiseased intima of the human aorta: a possible role in surveillance and maintenance of vascular homeostasis.
    • Anti-Atherosclerotic Therapy Based on Botanicals.
    • Strategies to deliver microRNAs as potential therapeutics in the treatment of cardiovascular pathology.
    • Diagnostic and Prognostic Value of Low Density Lipoprotein-Containing Circulating Immune Complexes in Atherosclerosis.
    • Low density lipoprotein-containing circulating immune complexes have better prognostic value in carotid intima-media thickness progression than other lipid parameters.
    • Mutation C3256T of Mitochondrial Genome in White Blood Cells: Novel Genetic Marker of Atherosclerosis and Coronary Heart Disease.
    • Mitochondrial mutations are associated with atherosclerotic lesions in the human aorta.
    • Increased shedding of microvesicles from intimal smooth muscle cells in athero-prone areas of the human aorta: implications for understanding of the predisease stage.
    • Pluronic block copolymers inhibit low density lipoprotein self-association.
    • Mitochondrial dysfunction and mitochondrial DNA mutations in atherosclerotic complications in diabetes.
    • Cultured cell systems for revelation of new drugs antiatherosclerotic effects and their mechanisms investigation
    • A new method of quantitative estimation of mutant allele in mitochondrial genome
    • Monocytes as a diagnostic marker of cardiovascular diseases.
    • Вариабельность показателя толщины комплекса интима медиа общих сонных артерий в московской городской популяции среди лиц без клинических проявлений атеросклероза.
    • Новый биомаркер в ранней диагностике цереброваскулярной патологии: диффузное интимо-медиальное утолщение сонных артерий.
    • Роль сиаловой кислоты в проявлении атерогенных свойств липопротеидами низкой плотности.
    • Иммунный холестерин в крови - прогностическая ценность.
    • Клеточные модели для поиска веществ, способствующих обратному транспорту холестерина.
    • The interaction of plasma sialylated and desialylated lipoproteins with collagen from the intima and media of uninvolved and atherosclerotic human aorta.
    • The effects of time-released garlic powder tablets on acute respiratory diseases in children.
    • Contents of mRNAs encoding endosome/lysosome components in normal human aorta and in stage II of atherogenesis: a hidden regulation.
    • Тест-система для изучения влияния фармакологических агентов на активацию моноцитов крови человека.
    • Анализ мутации митохондриального генома A1555G при атеросклерозе интимы аорты человека.
    • Детекция замены тимина на цитозин в позиции 3336 митохондриального генома при атеросклеротических поражениях человека.
    • Белок переноса фосфолипидов увеличивает отток клеточного холестерина и фосфолипидов, вызванный аполипопротеинами высокой плотности.
    • Сезонные изменения транссиалидазной активности сыворотки крови человека.
    • Correlation between lipid deposition, immune-inflammatory cell content and MHC class II expression in diffuse intimal thickening of the human aorta.
    • Опыт применения пребиотика пролонгированного действия алликор.
    • Полиморфизм 3256С/Т митохондриальной ДНК как маркер ишемической болезни сердца и атеросклероза.
    • Детекция митохондриальной делеции гуанина в позиции 652 при атеросклеротических поражениях человека.
    • Клеточные модели для поиска средств, способствующих обратному транспорту холестерина.
    • Изучение показателя толщины интимо-медиального слоя сонных артерий (ТИМ) как показателя естественного течения атеросклероза в московской популяции.
    • Массовая апробация эффективности пребиотического препарата «Алликор» в отношении показателей заболеваемости острыми респираторными вирусными инфекциями у детей.
    • Результаты апробации пребиотика «Алликор» в условиях оздоровительной программы по профилактике респираторных и сердечно-сосудистых заболеваний.
    • Исследование влияния белков, потенциально вовлеченных в отток холестерина, на экспорт холестерина из макрофагов.
    • Липопротеиды низкой плотности подавляют воспалительную реакцию моноцитов.
    • Индуцирующая роль вирусов острых респираторных вирусных инфекций в прогрессии атеросклеротического процесса.
    • Ультразвуковые признаки каротидного атеросклероза в диагностике ранних нарушений мозгового кровообращения.
    • Повреждение механизмов обратного транспорта холестерина, вызванное вирусом иммунодефицита человека: роль АВСА1-зависимого пути.
    • Возможная роль экологических факторов в формировании предрасположенности к развитию атеросклероза в московской популяции.
    • Time-released garlic powder tablets lower systolic and diastolic blood pressure in men with mild and moderate arterial hypertension.
    • Роль диффузного интимо-медиального утолщения сонных артерий в ранней диагностике цереброваскулярной патологии.
    • Peculiarities of cell composition and cell proliferation in different type atherosclerotic lesions in carotid and coronary arteries.
    • The effects of time-released garlic powder tablets on multifunctional cardiovascular risk in patients with coronary artery disease.
    • Прямая количественная оценка мутантного аллеля митохондриального генома.
    • Изучение программирующего эффекта половых гормонов на клеточной модели накопления холестерина.
    • Долговременная динамика изменений способности сыворотки крови человека вызывать накопление холестерина в клеточной тест-системе.
    • Выделение моноцитов из крови человека для изучения влияния факторов внешней среды на иммунитет.
    • Толщина интимо-медиального слоя сонных артерий как фенотипический маркер ишемической болезни сердца.
    • Оценка противовоспалительной активности препарата «Инфламинат» на животной модели воспаления.
    • Механизмы половых различий при атеросклерозе.
    • Сиаломика и атеросклероз.
    • Липопротеиды высокой плотности: терапевтические подходы (ЛВП-терапия).
    • [Proteomic analysis of the hematopoietic stem cell niche: focus on osteoblasts].
    • Клеточные механизмы атеросклероза: врожденный иммунитет и воспаление.
    • Влияние паратиреоидного гормона на протеом остеобластов.
    • Мутации митохондриального генома в патологии человека.
    • Ассоциация мутации митохондриального генома 652insG с атеросклеротическими поражениями человека.
    • Musashi-1 expression in atherosclerotic arteries and its relevance to the origin of arterial smooth muscle cells: Histopathological findings and speculations.
  • 2006-2008
    • Сравнительное содержание мРНК рецепторов и ферментов обмена половых стероидов в ткани артериальных сосудов мужчин.
    • Complex reduction of cardiovascular prognostic risk with time-released garlic powder tablets allicor.
    • Metabolic effects of time-released garlic powder tablets in type 2 diabetes mellitus: the results of double-blinded placebo-controlled study.
    • Sezary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3.
    • Activation of a TGF-beta-specific multistep gene expression program in mature macrophages requires glucocorticoid-mediated surface expression of TGF-beta receptor II.
    • Xeroderma pigmentosum-variant patients from America, Europe, and Asia.
    • Incidence of DNA repair deficiency disorders in western Europe: Xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy.
    • Alternatively activated macrophages regulate extracellular levels of the hormone placental lactogen via receptor-mediated uptake and transcytosis.
    • Studies of the human aortic intima by a direct quantitative assay of mutant alleles in the mitochondrial genome.
    • Deglycosylation of apo B-containing lipoproteins increase their ability to aggregate and to promote intracellular cholesterol accumulation in vitro.
    • Lipid-lowering effects of time-released garlic powder tablets in double-blinded placebo-controlled randomized study.
    • Связь размера дегликозилированных различными ферментами апо-В-содержащих липопротеидов с их атерогенным потенциалом.
    • Антиатерогенный эффект флавоноидов винограда в модели ex vivo.
    • Time-released garlic powder tablets protect from acute respiratory diseases and reduce overall mortality.
    • Multifactorial cardioprotective effects of time-released garlic powder tablets.
    • Заряд поверхностного слоя циркулирующих множественно модифицированных липопротеинов низкой плотности.
    • Влияние экстрактов растительного происхождения на активность транс-сиалидазы плазмы крови человека.
    • Подавление внутриклеточного накопления холестерина и экспрессии провоспалительных цитокинов в условиях клеточной модели.
    • Агрегация ЛПНП, индуцированная окислением, приводит к увеличению их захвата гладкомышечными клетками аорты человека.
    • Применение натуральных продуктов в антицитокиновой терапии.
    • Применение алликора для снижения риска инфаркта миокарда.
  • 2002-2005
    • Оценка эффективности алликора для снижения риска развития ишемической болезни сердца при первичной профилактике.
    • Протеолиз апопротеида В-100 нарушает его топографию на поверхности ЛПНП, снижая их устойчивость к ассоциации.
    • Гидролиз фосфолипидов фосфолипазами А2 и С нарушает конформацию аполипопротеина В-100 на поверхности липопротеидов низкой плотности, снижая их устойчивость к ассоциации.
    • Десиалирование снижает устойчивость апо-В-содержащих липопротеидов к ассоциации, повышая их атерогенный потенциал.
    • Снижение риска сердечно-сосудистых заболеваний при первичной профилактике ишемической болезни сердца.
    • Garlic powder tablets in direct prevention and treatment of atherosclerosis.
    • Сравнение устойчивости к ассоциации нативных и циркулирующих модифицированных ЛПНП крови человека.
    • Циркулирующие модифицированные ЛПНП крови человека склонны к ассоциации в условиях пониженной ионной силы.
    • Миелопероксидаза, модифицируя поверхность и снижая устойчивость к ассоциации липопротеинов низкой плотности крови человека, повышает их атерогенный потенциал.
    • Способ лечения мастопатии.
    • Гипотензивный эффект чесночных таблеток пролонгированного действия Алликор (двойное слепое плацебо-контролируемое исследование).
    • New insight into non-statin prevention and treatment of atherosclerosis.
    • Human plasma trans-sialidase donor and acceptor specificity.
    • Влияние чесночных таблеток пролонгированного действия Алликор на заболеваемость ОРВИ у детей.
    • Атерогенные холестеринсодержащие циркулирующие иммунные комплексы в сыворотке крови больных системной красной волчанкой.
    • Способ лечения хронического атрофического гастрита.
    • Коррекция гиперлипидемии препаратом Алликор.
    • Изучение антиоксидантного препарата «Каринат» как средства для лечения больных с хроническим атрофическим гастритом.
    • Выявление антигенных различий апо-В нативных и циркулирующих модифицированных ЛПНП.
    • Изучение антиоксидантной биологически активной добавки к пище "Каринат" у больных с фиброаденоматозом молочных желез.
    • [Effect of long-acting garlic tablets "allicor" on the incidence of acute respiratory viral infections in children]
    • [Atherogenic cholesterol-containing circulating immune complexes--one of the components of the serum in patients with systemic lupus erythematosus].
  • 1997-2001
    • Human plasma trans-sialidase causes atherogenic modification of low density lipoprotein.
    • Continuous subendothelial network formed by pericyte-like cells in human vascular bed.
    • Low-density lipoprotein modification occurring in human plasma possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification.
    • In vivo oxidized low density lipoprotein: degree of lipoprotein oxidation does not correlate with its atherogenic properties.
    • Cell proliferation in normal and atherosclerotic human aorta: proliferative splash in lipid-rich lesions.
    • Antioxidant content in low density lipoprotein and lipoprotein oxidation in vivo and in vitro.
    • Optimization of the assay for sialic acid determination in low density lipoprotein.
    • Многофакторная профилактика атеросклероза и атеросклеротических заболеваний.
    • Применение алликора для коррекции метаболизма при сахарном диабете: биохимические предпосылки и клинические исследования.
    • Прямое антиатеросклеротическое действие Алликора. Двойное слепое плацебо-контролируемое многоцентровое исследование.
    • The content of lipoperoxidation products in normal and atherosclerotic human aorta.
    • [Localization of collagen-synthesizing cells in normal and atherosclerotic intima of human aorta] [in Russian]
    • Lack of correlation between degree of human plasma low density lipoprotein oxidation and its atherogenic potential.
    • Metabolism of native and naturally occurring multiple modified low density lipoprotein in smooth muscle cells of human aortic intima.
    • Collagen-synthesizing cells in initial and advanced atherosclerotic lesions of human aorta
    • [Effect of the garlic tablets allicor on thrombocyte aggregation in vitro and ex vivo] [in Russian]
    • Effects of garlic on atherosclerosis.
    • In vitro effect of garlic powder extract on lipid content in normal and atherosclerotic human aortic cells.
    • Antiatherosclerotic and antiatherogenic effects of a calcium antagonist plus statin combination: amlodipine and lovastatin.
    • The effects of antihypertensive agents on atherosclerosis-related parameters of human aorta intimal cells.
    • [New prospects for the treatment of atherosclerosis: garlic preparations] [in Russian]
  • 1993-1996
    • Similarity between naturally occurring modified desialylated, electronegative and aortic low density lipoprotein.
    • [Multiple modifications of low density lipoproteins in blood of patients with atherosclerosis] [in Russian]
    • Apolipoprotein B-bound lipids as a marker for evaluation of low density lipoprotein oxidation in vivo.
    • Gap junctional communication in primary culture of cells derived from human aortic intima.
    • Diagnostic value of immune cholesterol as a marker for atherosclerosis.
    • [Intercellular communication studied by using the gap junctions in a primary cell culture of human aortic intima] [in Russian]
    • [Multiply-modified disialyated low-density lipoproteins: physico-chemical properties] [in Russian]
    • Characteristics of low density lipoprotein isolated from circulating immune complexes.
    • [Direct antiatherogenic effect of garlic] [in Russian]
    • Atherogenic modified LDL in diabetes.
    • [Lipid composition of polymodified (desialylated) low density lipoproteins] [in Russian]
    • [Immunocytochemical study to localize a scavenger receptor in human aorta smooth muscle cells] [in Russian]
    • [Protein-bound lipids in human low density lipoproteins] [in Russian]
    • Modified (desialylated) low-density lipoprotein measured in serum by lectin-sorbent assay.
    • Naturally occurring modified low density lipoproteins are similar if not identical: more electronegative and desialylated lipoprotein subfractions.
    • [Decrease in atherogenicity of blood serum in vitro under the effect of polyunsaturated phosphatidylcholine micelles] [in Russian]
    • Direct anti-atherosclerosis-related effects of garlic.
    • Heterogeneity of smooth muscle cells in embryonic human aorta.
    • [Atherogenic properties of oral sugar-reducing sulfonylurea derivatives] [in Russian]
    • Characterization of chemical composition of native and modified low density lipoprotein occurring in the blood of diabetic patients.
    • Sulfonylureas induce cholesterol accumulation in cultured human intimal cells and macrophages.
    • [The antiatherosclerotic effect of verapamil in a cell culture of human aortic intima] [in Russian]
    • [Atherogenic properties of blood serum in children with type I diabetes mellitus] [in Russian]
    • Carbohydrate composition of protein and lipid components in sialic acid-rich and -poor low density lipoproteins from subjects with and without coronary artery disease.
    • Modified low density lipoprotein from diabetic patients causes cholesterol accumulation in human intimal aortic cells.
    • Characteristics of low-density lipoprotein subfractions from patients with coronary artery disease.
    • [Effect of squid liver fat and krill meat on blood serum atherogenicity in patients with type I diabetes mellitus] [in Russian]
    • [Atherogenic potential of blood serum in patients with type I diabetes mellitus] [in Russian]
    • Autoantibodies against low-density lipoprotein and atherogenic potential of blood.
    • [Atherogenic effect of sugar-reducing drugs of the sulfonylurea group and its elimination using papaverine chloride] [in Russian]
    • Effect of lipoprotein (a) on lipid metabolism of cultured human intimal aortic cells.
  • 1991-1992
    • Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization.
    • [The structure of the endothelialized and nonendothelialized areas of myointimal thickening of the rabbit aorta] [in Russian]
    • The atherogenic effect of lupus sera: systemic lupus erythematosus-derived immune complexes stimulate the accumulation of cholesterol in cultured smooth muscle cells from human aorta.
    • [Effects of lovastatin therapy on the level of low density lipoproteins and atherogenic potential of serum in patients with ischemic heart disease and hypercholesterolemia] [in Russian]
    • [Atherogenic properties of phenothiazine drugs manifesting in cultured cells of the human aortic intima] [in Russian]
    • Sialic acid content of human low density lipoproteins affects their interaction with cell receptors and intracellular lipid accumulation.
    • Three types of naturally occurring modified lipoproteins induce intracellular lipid accumulation due to lipoprotein aggregation.
    • Beta-blockers: propranolol, metoprolol, atenolol, pindolol, alprenolol and timolol, manifest atherogenicity on in vitro, ex vivo and in vivo models. Elimination of propranolol atherogenic effects by papaverine.
    • Lipid-laden white blood cells in the circulation of patients with coronary heart disease.
    • [Carbohydrate composition of native and desialylated low density lipoproteins in the plasma of patients with coronary atherosclerosis] [in Russian]
    • [The effect of calcium antagonists on cholesterol metabolism in human aortal intima cells and macrophage lines] [in Russian]
    • [Seasonal variations of the lipid spectrum in patients with post-infarction cardiosclerosis and arterial hypertension] [in Russian]
    • Use of cultured atherosclerotic cells for investigation of antiatherosclerotic effects of anipamil and other calcium antagonists.
    • Influence of a cholesterol rich diet in rabbits on the formation of PGI2 and TXA2.
    • [Comparison between seasonal changes in lipid indicators in patients with post-infarction cardiosclerosis and arterial hypertension in Ashkhabad and Moscow] [in Russian]
    • Stellate cells of aortic intima: I. Human and rabbit.
    • Stellate cells of aortic intima: II. Arborization of intimal cells in culture.
    • Use of cell culture for optimisation of direct antiatherogenic therapy with verapamil.
    • Characterization of desialylated low-density lipoproteins which cause intracellular lipid accumulation.
    • [Elimination of the atherogenic effect of beta blocker propranolol by papaverine] [in Russian]
    • Three types of naturally occurring modified lipoproteins induce intracellular lipid accumulation in human aortic intimal cells--the role of lipoprotein aggregation.
    • [Relations between the levels of lipoprotein-containing immune complexes and lipids in the blood of patients with ischemic heart disease] [in Russian]
    • [Circulating immune complex cholesterol as a biochemical marker of coronary atherosclerosis] [in Russian]
    • [The cellular polymorphism of the myointimal thickening in the rabbit aorta] [in Russian]
    • Desialylated low density lipoprotein--naturally occurring modified lipoprotein with atherogenic potency.
    • Autoantibodies against modified low density lipoprotein. Nonlipid factor of blood plasma that stimulates foam cell formation.
    • Three-dimensional cytoarchitecture of normal and atherosclerotic intima of human aorta.
    • [Atherogenic effect of beta-blocker propranolol revealed in the rabbit denudated aorta] [in Russian]
    • Synergetic effect of desialylated and glycated low density lipoproteins on cholesterol accumulation in cultured smooth muscle intimal cells.
    • [Combined effects of desialylated and glycosylated low density lipoproteins on lipid content of human aortic intima cells in vitro] [in Russian]
    • [Atherogenic properties of sera and low-density lipoproteins in patients with diabetes mellitus] [in Russian]
    • Atherogenicity of autoantibodies against low density lipoprotein.
    • [Structure of the neointima after balloon catheter injury of the rabbit aorta in the context of hypercholesterolemia: analysis of endothelial influence on lipid accumulation] [in Russian]
    • Cholesterol level in circulating immune complexes as a marker of coronary atherosclerosis.
    • Antibody-like immunoglobulins G against low density lipoprotein that stimulate lipid accumulation in cultured cells.
    • [Changes in the 3-dimensional organization of the cellular system of the human aortic intima in atherosclerosis] [in Russian]
    • [The cholesterol content in immune complexes as a marker of coronary and peripheral atherosclerosis] [in Russian]
    • Lipoprotein immune complexes as markers of atherosclerosis.
    • Quantitative estimation of lipid-laden cells in atherosclerotic lesions of the human aorta.
    • Use of human atherosclerotic cells for optimization of antiatherosclerotic therapy.
    • Lipids in cells of atherosclerotic and uninvolved human aorta. III. Lipid distribution in intimal sublayers.
  • 1989-1990
    • [Blood lipophages in patients with ischemic heart disease] [in Russian]
    • In vitro models of anti-atherosclerotic effects of cardiovascular drugs.
    • [Isolation of desialylated low density lipoproteins from the blood of patients with ischemic heart disease by affinity chromatography] [in Russian]
    • Triggerlike stimulation of cholesterol accumulation and DNA and extracellular matrix synthesis induced by atherogenic serum or low density lipoprotein in cultured cells.
    • Local prevention of thrombosis in animal arteries by means of magnetic targeting of aspirin-loaded red cells.
    • Isolation of atherogenic modified (desialylated) low density lipoprotein from blood of atherosclerotic patients: separation from native lipoprotein by affinity chromatography.
    • Correlation between cholesterol content in circulating immune complexes and atherogenic properties of CHD patients' serum manifested in cell culture.
    • Antiatherosclerotic effects of calcium antagonists. Study in human aortic cell culture.
    • [Effects of beta adrenergic blocking agents and calcium antagonists on atherogenic properties of blood serum of patients with ischemic heart disease] [in Russian]
    • Low density lipoprotein-containing circulating immune complexes and coronary atherosclerosis.
    • [Aggregates of modified low density lipoproteins indicate accumulation of lipids in human aortic intima cells in vitro] [in Russian]
    • [Incidence among men of atherogenic potential of the serum detected in a culture of mouse peritoneal macrophages] [in Russian]
    • [Desialylated low density lipoproteins--atherogenic lipoproteins occurring in blood of patients with coronary atherosclerosis] [in Russian]
    • [Lysosomal proteinases of the human aortal intima and atherogenesis] [in Russian]
    • Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells: discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patients.
    • Lipoprotein aggregation as an essential condition of intracellular lipid accumulation caused by modified low density lipoproteins.
    • [Cholesterol-containing circulating immune complexes--a component of the blood serum in patients with ischemic heart disease that determines its atherogenic properties] [in Russian]
    • Insolubilization of low density lipoprotein induces cholesterol accumulation in cultured subendothelial cells of human aorta.
    • [The effect of glucagon and concanavalin A on cholesterol accumulation in mouse peritoneal macrophages and human aorta intima cells] [in Russian]
    • Peritoneal macrophages: a model for detecting atherogenic potential in patients' blood serum.
    • [The use of freeze fracturing in combination with light, scanning and transmission electron microscopy for studying the structure of the normal and atherosclerotically altered human aortic intima] [in Russian]
    • [Peritoneal macrophages as a model for the study of the atherogenic potential of the blood serum] [in Russian]
    • [Low density lipoproteins isolated from the blood of patients with ischemic heart disease induce accumulation of lipids in human aortic intima cells] [in Russian]
    • [Anti-atherosclerotic properties of higher mushrooms (a clinico-experimental investigation)] [in Russian]
    • Use of lipophilic fluorescent probes for the isolation of hybrid cells in flow cytometry.
    • Neutral glycolipids of atherosclerotic plaques and unaffected human aorta tissue.
    • [The effect of eicosapentaenoic acid and various prostaglandins on cholesterol accumulation and proliferation of intima cells from human aorta] [in Russian]
    • [Effect of medicinal leech preparations on indicators of atherogenesis] [in Russian]
    • [The content of cyclic nucleotides in an organ culture of normal and atherosclerosis-affected human aorta] [in Russian]
    • [Anti-atherosclerotic properties of eicosapentaenoic acid: clinico-experimental study] [in Russian]
    • Low-density lipoproteins isolated from the blood of patients with coronary heart disease induce the accumulation of lipids in human aortic cells.
    • [Atherogenic properties of beta adrenergic blockaders evident on vascular wall cells] [in Russian]
    • Ganglioside content and composition of cells from normal and atherosclerotic human aorta.
  • 1986-1988
    • Blood serum atherogenicity associated with coronary atherosclerosis. Evidence for nonlipid factor providing atherogenicity of low-density lipoproteins and an approach to its elimination.
    • Atherogenic effects of beta blockers on cells cultured from normal and atherosclerotic aorta.
    • Stable analogues of prostacyclin and thromboxane A2 display contradictory influences on atherosclerotic properties of cells cultured from human aorta. The effect of calcium antagonists.
    • Modulation of human aorta smooth muscle cell phenotype: a study of muscle-specific variants of vinculin, caldesmon, and actin expression.
    • Prevention of experimental carotid artery thrombosis by magnetic vectoring of aspirin [letter]
    • [Effect of components of the extracellular matrix on the accumulation of lipids in human cells] [in Russian]
    • [Decreased lipid levels in arteriosclerotic plaques of the human aorta after LDL-apheresis (an in vitro study)] [in Russian]
    • Spontaneous atherosclerotic plaque and obstruction of distal anastomosis in femoral artery. Comparative morphologic study.
    • Cyclic nucleotides and atherosclerosis: studies in primary culture of human aortic cells.
    • [Effect of lipostabil on cholesterol levels in atherosclerotic plaques of the human aorta and the aggregative capacity of thrombocytes (in vitro study)] [in Russian]
    • Intracellular cholesterol accumulation is accompanied by enhanced proliferative activity of human aortic intimal cells.
    • Cardiovascular drugs and atherosclerosis: effects of calcium antagonists, beta-blockers, and nitrates on atherosclerotic characteristics of human aortic cells.
    • The effects of eicozanoids and lipoxygenase inhibitors on the lipid metabolism of aortic cells.
    • Prostacyclin, thromboxane A2 and calcium antagonists: effects on atherosclerotic characteristics of vascular cells.
    • [Comparison of 2 methods of flow cytofluorometric analysis of epithelial cells in the diagnosis of uterine cervix cancer] [in Russian]
    • On the role of cyclic nucleotides in the pathogenesis of human atherosclerosis.
    • Is prostacyclin a major prostaglandin produced by endothelial cells in culture?
    • Disorders in the system of cyclic nucleotides in atherosclerosis: cyclic AMP and cyclic GMP content and activity of related enzymes in human aorta.
    • Evidence of antiatherosclerotic action of verapamil from direct effects on arterial cells.
    • Association of low-density lipoprotein with particulate connective tissue matrix components enhances cholesterol accumulation in cultured subendothelial cells of human aorta.
    • Trapidil derivatives as potential antiatherosclerotic drugs.
    • [Local prevention of thrombosis in the dog carotid artery using magnetically concentrated erythrocytes loaded with aspirin] [in Russian]
    • The gangliosides of adult human aorta: intima, media and plaque.
    • Diabetes mellitus and atherosclerosis [letter]
    • Adult human aortic cells in primary culture: heterogeneity in shape.
    • Agents that increase cellular cyclic AMP inhibit proliferative activity and decrease lipid content in cells cultured from atherosclerotic human aorta.
    • Cyclic AMP and cyclic GMP content in a short-term organ culture of normal and atherosclerotic human aorta.
    • Monoclonal antibody reveals heterogeneity in human aortic intima: detection of a ganglioside antigen associated with a subpopulation of intimal cells [published erratum appears in Am J Pathol 1986 May;123(2):379]
    • Primary culture of human aortic intima cells as a model for testing antiatherosclerotic drugs. Effects of cyclic AMP, prostaglandins, calcium antagonists, antioxidants, and lipid-lowering agents.
    • Atherogenicity of blood serum from patients with coronary heart disease.
    • Effect of cyclic AMP on lipid accumulation and metabolism in human atherosclerotic aortic cells.
    • Intimal cells and atherosclerosis. Relationship between the number of intimal cells and major manifestations of atherosclerosis in the human aorta.
    • Low-density lipoprotein apheresis and regression of atherosclerotic plaque in vitro.
    • Comparative investigations of the reoccluded distal anastomosis, the spontaneous atherosclerotic plaque and the normal intima of the human femoral artery.
  • 1974-1985
    • [Study of the structural and functional properties of fibronectin--a high molecular weight plasma glycoproteins--by using monoclonal antibodies] [in Russian]
    • Content and localization of fibronectin in normal intima, atherosclerotic plaque, and underlying media of human aorta.
    • Artificial HDL as an anti-atherosclerotic drug [letter]
    • [Cellular composition and biochemical characteristics of the human aorta] [in Russian]
    • Lipids in cells of atherosclerotic and uninvolved human aorta. I. Lipid composition of aortic tissue and enzyme-isolated and cultured cells.
    • Primary RIA screening of hybridoma supernatants without use of a negative control.
    • Determination of total intracellular lipid content by flow cytofluorometry.
    • LDL apheresis and regression of atherosclerosis [letter]
    • Lipids in cells of atherosclerotic and uninvolved human aorta. II. Lipid metabolism in primary culture.
    • [Concentration of erythrocyte-based magnetic carriers in the vascular bed] [in Russian]
    • [Immunomorphological study of the localization of types I, III, IV and V collagen in a primary culture of human aortic cells] [in Russian]
    • Dissociated cells from different layers of adult human aortic wall.
    • Primary cultures of enzyme-isolated cells from normal and atherosclerotic human aorta.
    • Regression of atherosclerotic manifestations in primary culture of human aortic cells: effects of prostaglandins.
    • Enzymatic detoxication of superoxide anion-radicals and lipoperoxides in intima and media of atherosclerotic aorta.
    • [Determination of the lipid content of a single cell by flow cytofluorometry] [in Russian]
    • Heterogeneity of human aortic cells in regard to RNA content.
    • [Decrease in the lipid content of human atherosclerotic aorta cells as affected by compounds increasing the intracellular level of cyclic AMP] [in Russian]
    • [Immunomorphological study of fibronectin localization in a primary human aorta cell culture] [in Russian]
    • Cellular composition of atherosclerotic and uninvolved human aortic subendothelial intima. Light-microscopic study of dissociated aortic cells.
    • [Detection of 2 cell subpopulations each differing in incorporating low-density lipoproteins in an atherosclerotic plaque from the human aorta] [in Russian]
    • Dibutyryl cyclic AMP decreases proliferative activity and the cholesteryl ester content in cultured cells of atherosclerotic human aorta.
    • Stellate cells in the intima of human aorta. Application of alkaline dissociation method in the analysis of the vessel wall cellular content.
    • [Use of perilenoyl-labelled triglyceride as a fluorescent probe for staining lipid inclusions in cultured cells] [in Russian]
    • Cell proliferation in normal and atherosclerotic human aorta. I. Flow cytofluorometric determination of cellular deoxyribonucleic acid content.
    • [Effect of dibutyryl-cAMP on the cholesterol ester content in human atherosclerotic aorta cells] [in Russian]
    • Cell proliferation in normal and atherosclerotic human aorta. II. Autoradiographic observation on deoxyribonucleic acid synthesis in primary cell culture.
    • [3H-thymidine incorporation into human aorta cells in primary culture. An autoradiographic study] [in Russian]
    • Prostacyclin analogues as antiatherosclerotic drugs [letter]
    • [Content of lipids in cells, isolated from normal and atherosclerotically-altered portions of the human aorta] [in Russian]
    • [Role of endogenic substances in creating a background of increased radioresistance. 3. The role of endogenic serotonin] [in Russian]
    • [Role of endogenous substances in developing a basis for increased radiation resistance. 4. Effect of serotonin on lipid radiation sensitizers] [in Russian]
    • [A method of determining adenylate cyclase activity] [in Russian]
    • [Role of endogenous substances in the creation of a background of increased radioresistance. Report 7. Study of the influence of dopamine and histamine on lipid radiosensitizers] [in Russian]
    • [Effect of radiation-protective preparations on the level of cyclic adenosine-3',5'-monophosphate (cycl AMP), adenylate cyclase and cycl AMP phosphodiesterase] [in Russian]
    • [Effect of ionizing radiation on the activity of adenylate cyclase, cAMP phosphodiesterase and the level of cAMP in mouse liver] [in Russian]
    • [Post-radiation disorders in the cyclic AMP system of mouse spleen and thymus lymphoid cells] [in Russian]
    • [Polymorphism of human aortic cells in culture] [in Russian]
    • [RNA content of cells isolated from normal and arteriosclerotic human aorta] [in Russian]
    • [Lipid metabolism in cells of human atherosclerotic aorta. Study in the primary culture] [in Russian]
• Монографии
  • Семейная гиперхолестеринемия и ишемическая болезнь сердца
  • Дефекты митохондриального генома и атеросклероз
  • Атерогенная модификация липопротеидов
  • Терапия атеросклероза на основе препаратов природного происхождения
  • Direct anti-atherosclerotic therapy
  • Качество и безопасность биологически активных добавок к пище
  • Атеросклероз. Молекулярно-клеточные механизмы атерогенеза человека. Антиатеросклеротическая терапия
  • Принципы патогенетической терапии атеросклероза. Использование клеточных моделей.
  • Модифицированные липопротеиды и атеросклероз. Обнаружение, характеристика, механизмы модификации, атерогенность.
  • Атерогенность липопротеидов. Механизмы, роль, ассоциации.
  • Протеомика атерогенеза. Белковый профиль поражения и потенциал стволовых клеток
  • Половые различия атеросклероза. Молекулярно-клеточные и клинико-неврологические особенности.
• Гранты
• Лекции и доклады
  • Лекции международной молодежной научной школы
    • Лекция «Гетероплазмия митохондриального генома: методы диагностики»
      • 2
      • 3
      • 4
      • 5
      • 6
    • Лекция «Митохондриальный геном: структура и функции, особенности репликации»
      • 2
      • 3
    • Лекция «Мутационная нагрузка митохондриального генома и генетическая предрасположенность к атеросклерозу»
      • 2
      • 3
      • 4
      • 5
      • 6
      • 7
      • 8
      • 9
    • Лекция «Функциональная характеристика новых генов и метаболических путей при низком уровне липопротеидов высокой плотности»
      • 1
      • 2
      • 3
      • 4
      • 5
      • 6
      • 7
      • 8
      • 9
      • 10
      • 11
    • Лекция «Молекулярно-клеточные механизмы атерогенеза»
      • Клеточный состав
      • Атеросклеротические изменения
      • Клеточные механизмы атеросклероза.
  • Endoplasmic reticulum stress related genes and the foam cell formation
  • Atherogenic potential of human blood: basic research and development of novel antiatherosclerotic therapy
  • Natural products for anti-atherosclerotic therapy
  • Atherogenic potential of human blood: basic research and development of novel anti-atherosclerotic therapy
  • Alexander Orekhov. Cellular Mechanisms of Atherogenesis and Development of Antiatherosclerotic Drugs
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    • 15
    • 16
    • 17
    • 18
    • 19
    • 20
    • 21
    • 22
    • 23
• Архив объявлений
  • Специализированные курсы от Центра сертификации и подготовки специалистов по биокорректорам
  • Консультация по профилактике, диагностике и лечению атеросклероза.
  • Открылся новый кабинет УЗИ На базе санатория-профилактория МИСиС
  • Проведение контрактных исследований
  • Институт атеросклероза ("Сколково") приглашает студентов для выполнения курсовой или дипломной работы
  • Требуется сотрудник для работы с базами данных
  • Научная школа для молодежи "Российско-скандинавская школа "Генодиагностика атеросклероза. Митохондриальный геном""
• Партнеры
• Патенты
  • Заявка на патент "Новые ингибиторы сиалидазы на основе углеродных каркасов оксазолинонов, полученные путем химического синтеза"
  • Заявка на патент "Цибридная клеточная линия, содержащая мутацию митохондриального генома m.3256C>T, ассоциированную с атеросклерозом"
  • Заявка на патент "Цибридная клеточная линия, содержащая мутацию митохондриального генома m.652insG, ассоциированную с протективным (защитным) эффектом при атеросклерозе, созданная на основе культуры моноцитарного происхождения THP-1"
  • Заявка на патент «НОВАЯ ГЕНЕТИЧЕСКАЯ КОНСТРУКЦИЯ НА ОСНОВЕ SNIPERCAS ДЛЯ УДАЛЕНИЯ МИТОХОНДРИАЛЬНОЙ ДНК, НЕСУЩЕЙ АТЕРОГЕННУЮ МУТАЦИЮ M.15059G>A»
  • Патент "Средство для подавления экспрессии генов, связанных с накоплением холестерина макрофагами человека" № 2698199 от 23 августа 2019 г.
  • Патент "Способ выявления предрасположенности к заболеванию атеросклерозом на основе определения экспрессии генов, вовлеченных в накопление холестерина" № 2698092 от 22 августа 2019 г.
  • Патент "Способ измерения концентрации циркулирующих модифицированных липопротеидов низкой плотности в сыворотке крови человека" № 2659211 от 28 июна 2018 г.
  • Патент "Способ оценки содержания циркулирующих десиалированных липопротеидов низкой плотности" № 2623879 от 29 июня 2017 г.
  • Патент "Способ оценки генетического риска атеросклероза на основе определения вариантов митохондриального генома" № 2592233 от 28 июня 2016 г.
  • Патент "Способ лечения атеросклероза, основанный на антицитокиновом действии" № 2539377 от 02 декабря 2014 г.
  • Патент "Иммунокорректирующее средство для терапии атеросклеротических заболеваний" № 2539133 от 26 ноября 2014г.
  • Патент "Method for detection of predisposition to atherosclerosis, coronary heart disease and related conditions" от 30 мая 2013г.
  • Патент "Method for detection of predisposition to atherosclerosis, coronary heart disease and related conditions" 19 мая 2011г.
  • Патент "Способ профилактики атеросклероза, основанный на подавлении атерогенной модификации липопротеидов" № 2484841 от 20 июня 2013 г.
  • Патент "Способ профилактики и лечения атеросклероза" № 2455016 от 10 июля 2012г.
  • Патент "Способ лечения мастопатии" от 10 апреля 2004г.
  • Патент "Способ лечения хронического атрофического гастрита" № 2219940 от 25 июля 2002г.
  • Патент "Ярлык-этикетка" № 47100 от 18 ноября 1999 г.
  • Патент "Средство, пролонгирующее эффективность чесночного порошка" № 2141828 от 26 марта 1998г.
  • Патент "Средство "Каринат" для профилактики сердечно-сосудистых и онкологических заболеваний" № 2129874 от 26 марта 1998г.
  • Патент "Средство для профилактика атеросклероза" № 2082427 от 27 июня 1997г.
• О нас пишут
  • Сергей Поляков выступил перед участниками совместных проектов фонда и международного бюро министерства науки и исследований германии
  • Научно-исследовательский институт «Нутрициология и здоровое долголетие»​
  • Научно-исследовательский институт атеросклероза
  • Как связаны воспаление и атеросклероз
  • Ученые выяснили, с чего начинается атеросклероз
  • Найдены подробности развития атеросклероза
  • Российские ученые нашли воспалительную причину атеросклероза
  • Биологи, возможно, выявили истинные причины развития атеросклероза
  • Ученые: атеросклероз начинается с воспаления
  • Выявлена связь воспаления и атеросклероза
  • Российские биологи раскрыли истинную причину развития атеросклероза
  • Российские ученые нашли способ предотвращения атеросклероза
• Контракты
  • Research grants and contracts
• Наши награды и сертификаты
• Сотрудники
  • Орехов Александр Николаевич
  • Мельниченко Александра Александровна
  • Карагодин Василий Петрович
  • Романенко Елена Борисовна
  • Полунина Людмила Ивановна
  • Сазонова Маргарита Александровна
  • Кириченко Татьяна Владимирована
  • Мясоедова Вероника Александровна
  • Иванова Екатерина Александровна
  • Гланц Виктор Юрьевич
  • Никифоров Никита Геннадьевич
  • Маркин Александр Михайлович
  • Маркина Юлия Владимирована
  • Хасанова Зухра Биляловна
  • Сухоруков Василий Николаевич
  • Синёв Василий Владимирович
  • Орехова Варвара Александровна
  • Каширских Дмитрий Александрович
  • Хотина Виктория Александровна
  • Елизова Наталья Владимировна
  • Колмычкова Кира Ивановна
  • Сазонова Марина Дмитриевна
  • Рыжкова Анастасия Игоревна
  • Воропаева Надежда Петровна
  • Бондаренко Наиля Фаиковна
  • Самерхил Вольга
  • Позняк Анастасия
• Методические рекомендации

Верхнее меню

• История института
• Резюме
• Вакансии
• Контакты
• Поиск